CDH17 and breast cancer: Cioffi et al. performed sE-cadherin level measurements in 79 lung cancer patients and 52 non-lung cancer subjects (9 with breast cancer, 10 with benign pulmonary disease, 13 with non-pulmonary disease and 20 healthy controls).